Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Researchers publish new studies and findings in the area of angiology
August 26th, 2005
New findings from Germany, the United States and the United Kingdom describe advances in angiology. Study 1: Midostaurin upregulates eNOS gene expression and preserves eNOS function in the microcirculation of the mouse. "Nitric oxide (NO) derived from endothelial NO synthase (eNOS) is a powerful vasodilator and possesses vasoprotective effects. Therefore, augmentation of eNOS expression and -activity by pharmacological means could provide protection against cardiovascular disease. However, this concept has been questioned recently, because in several disease models, eNOS upregulation was associated with a dysfunctional enzyme (referred to as eNOS...
Source: Drug Week (2005-08-26)
|
